View:
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
- --------------------------------------------------------------------------------
FORM 8-K
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) October 18, 1995
CONMED CORPORATION
-----------------------------------------------------
(Exact name of registrant as specified in its charter)
New York 0-16093 16-0977505
- ------------------------------- ------------ --------------------
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
310 Broad Street, Utica, New York 13501
- ---------------------------------------- ---------
(Address of principal executive offices) (Zip Code)
(315) 797-8375
---------------------------------------------------
(Registrant's telephone number, including area code)
Item 5. Other Events
On October 18, 1995, the Registrant issued the attached press
release relative to the acquisition of a business and certain assets.
Item 7. Financial Statements and Exhibits
(c) Exhibits
1. Press release dated October 18, 1995
Signature
Pursuant to the requirements of Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CONMED CORPORATION
/s/ Robert D. Shallish, Jr.
By: Robert D. Shallish, Jr.
Vice President-Finance
Dated: October 20, 1995
October 18, 1995
FOR RELEASE: 6:00 PM EDT OCTOBER 18, 1995
CONTACT: ROBERT D. SHALLISH, JR.
(315)797-8375 EXT. 2219
CONMED CORPORATION WILL ACQUIRE
NEW DIMENSIONS IN MEDICINE, INC.
Utica, New York - CONMED Corporation (NASDAQ:CNMD) and New Dimensions
in Medicine, Inc. (NASDAQ/OTC:NDIM) have announced the signing of an asset
purchase agreement in which CONMED will acquire substantially all of the
business and assets of NDM except for NDM's international wound care business,
for a cash purchase price of approximately $32,000,000. The transaction is
subject to standard governmental approvals and the approval of the shareholders
of NDM. Subject to receiving such approvals, the parties expect to close the
transaction in late 1995 or early 1996.
NDM is a developer and manufacturer of electrocardiograph (ECG)
monitoring electrodes, electrosurgical products and hydrogel wound dressings.
Annual sales of NDM products to be sold by CONMED after the acquisition
approximate $28,000,000.
Mr. Eugene R. Corasanti, Chairman and President of CONMED said "We are
extremely pleased to acquire the NDM ECG and electrosurgery products as they
complement our own products in these markets. We are also excited about the NDM
wound care business as it represents a new group of products for our Company to
market."
Mr. William F. Shea, Chairman and President of NDM said "We are pleased
to announce the sale of our business to CONMED. We have terminated our
previously announced discussions with Tyco International for the sale of our
business because we believe the CONMED transaction will result in significantly
higher value to NDM's shareholders. NDM estimates that the net proceeds to be
distributed to its shareholders from the CONMED transaction and the previously
announced sale of NDM's international wound care business to another buyer will
be approximately $5.00 per share subject to change depending upon the
disposition of excluded assets and liabilities."
CONMED is a manufacturer and world-wide distributor of electrosurgery,
heart monitoring and other medical products used primarily in hospital operating
rooms and other critical care areas.